Drug firms admit to colluding in order to keep prices up
The move comes as part of a competition law investigation by the Competition and Markets Authority (CMA) into drug firms King Pharmaceuticals Limited, Alissa Healthcare Research Limited and Lexon (UK) Limited. In June 2019, the CMA issued a statemen… read more